General Biologicals Market Cap

General Biologicals has a market cap or net worth of 252.42 million as of April 29, 2026. Its market cap has decreased by -77.51% in one year.

Market Cap

252.42M

Enterprise Value

2.57B

Revenue

251.38M

Ranking

n/a

PE Ratio

n/a

Stock Price

4.15

Market Cap Chart

Since February 21, 2005, General Biologicals's market cap has decreased from 326.98M to 252.42M, a decrease of -22.80%. That is a compound annual growth rate of -1.22%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2026	252.42M	-67.70%
Dec 31, 2025	781.60M	-38.66%
Dec 31, 2024	1.27B	-21.11%
Dec 29, 2023	1.62B	0.37%
Dec 30, 2022	1.61B	-22.70%
Dec 30, 2021	2.08B	-35.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniPharma	504.11M
Golden Biotechnology	562.93M
Bioray Biotech	656.79M
Mediera	994.25M
Original BioMedicals	1.01B
Anxo Pharmaceutical	1.07B
Prince Pharmaceutical	1.08B
Excelsior Biopharma	1.18B

Market Cap Rankings